Drug Profile
WIN 68881
Latest Information Update: 07 Jun 1995
Price :
$50
*
At a glance
- Originator Sanofi Winthrop
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Viral infections
Most Recent Events
- 06 Jun 1995 New profile
- 06 Jun 1995 Discontinued-Preclinical for Viral infections in USA (Unknown route)